Tokyo Tape
Sign in
← Sakai Chemical Industry

Quarterly report · Q2

4078.TEDINET S100S5CT
Period2023-04-01 → 2023-09-30
Filed2023-11-08
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥40.5bn2023-04-01 → 2023-09-30Cons.Net sales
Revenue¥83.9bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥42.7bn2022-04-01 → 2022-09-30Cons.Net sales
Operating income¥917m2023-04-01 → 2023-09-30Cons.Operating income
Operating income¥3.3bn2022-04-01 → 2022-09-30Cons.Operating income
Ordinary income¥885m2023-04-01 → 2023-09-30Cons.Ordinary income
Ordinary income¥4.6bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥3.8bn2022-04-01 → 2022-09-30Cons.Ordinary income
Profit before tax¥773m2023-04-01 → 2023-09-30Cons.Income before income taxes
Profit before tax¥4.2bn2022-04-01 → 2022-09-30Cons.Income before income taxes
Net income (owners)−¥2.0bn2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥2.3bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥2.9bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income−¥1.8bn2023-04-01 → 2023-09-30Cons.Profit loss
Net income¥3.0bn2022-04-01 → 2022-09-30Cons.Profit loss
Total assets¥131.6bnat 2023-09-30Cons.Assets
Total assets¥128.0bnat 2023-03-31Cons.Assets
Total assets¥128.4bnat 2022-09-30Cons.Total assets (5-year summary)
Total liabilities¥50.9bnat 2023-09-30Cons.Liabilities
Total liabilities¥43.3bnat 2023-03-31Cons.Liabilities
Net assets / equity¥80.7bnat 2023-09-30Cons.Net assets
Net assets / equity¥84.7bnat 2023-03-31Cons.Net assets
Net assets / equity¥85.8bnat 2022-09-30Cons.Net assets (5-year summary)
Cash and deposits¥15.6bnat 2023-09-30Cons.Cash and deposits
Cash and deposits¥12.4bnat 2023-03-31Cons.Cash and deposits
Cash & equivalents¥15.5bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥12.2bnat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥11.7bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥10.5bnat 2022-03-31dCons.Cash and cash equivalents
Operating cash flow¥3.2bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥773m2022-04-01 → 2023-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥1.1bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥1.6bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥2.6bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥1.3bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Financing cash flow¥1.6bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
Financing cash flow¥3.3bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥1.0bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥-125.532023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-153.572023-07-01 → 2023-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥144.852022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥177.482022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥68.082022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio60.5%at 2023-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio62.9%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio63.6%at 2022-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-09-30−¥635m
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-09-30−¥635m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-09-30−¥1.1bn
jpcrp040300-q2r_E00780-000Chemicalreportable segmentrevenue2023-04-01 → 2023-09-30¥36.8bn
jpcrp040300-q2r_E00780-000Chemicalreportable segmentrevenue external2023-04-01 → 2023-09-30¥36.3bn
jpcrp040300-q2r_E00780-000Chemicalreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥498m
jpcrp040300-q2r_E00780-000Chemicalreportable segmentsegment profit2023-04-01 → 2023-09-30¥1.9bn
jpcrp040300-q2r_E00780-000Medicine And Health Carereportable segmentrevenue2023-04-01 → 2023-09-30¥4.3bn
jpcrp040300-q2r_E00780-000Medicine And Health Carereportable segmentrevenue external2023-04-01 → 2023-09-30¥4.2bn
jpcrp040300-q2r_E00780-000Medicine And Health Carereportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥136m
jpcrp040300-q2r_E00780-000Medicine And Health Carereportable segmentsegment profit2023-04-01 → 2023-09-30¥144m
—segment totalrevenue2023-04-01 → 2023-09-30¥41.1bn
—segment totalrevenue external2023-04-01 → 2023-09-30¥40.5bn
—segment totalrevenue intersegment2023-04-01 → 2023-09-30¥635m
—segment totalsegment profit2023-04-01 → 2023-09-30¥2.0bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-09-30−¥860m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-09-30−¥860m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-09-30−¥1.1bn
jpcrp040300-q2r_E00780-000Chemicalreportable segmentrevenue2022-04-01 → 2022-09-30¥39.3bn
jpcrp040300-q2r_E00780-000Chemicalreportable segmentrevenue external2022-04-01 → 2022-09-30¥38.6bn
jpcrp040300-q2r_E00780-000Chemicalreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥697m
jpcrp040300-q2r_E00780-000Chemicalreportable segmentsegment profit2022-04-01 → 2022-09-30¥4.2bn
jpcrp040300-q2r_E00780-000Medicine And Health Carereportable segmentrevenue2022-04-01 → 2022-09-30¥4.3bn
jpcrp040300-q2r_E00780-000Medicine And Health Carereportable segmentrevenue external2022-04-01 → 2022-09-30¥4.1bn
jpcrp040300-q2r_E00780-000Medicine And Health Carereportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥163m
jpcrp040300-q2r_E00780-000Medicine And Health Carereportable segmentsegment profit2022-04-01 → 2022-09-30¥240m
—segment totalrevenue2022-04-01 → 2022-09-30¥43.6bn
—segment totalrevenue external2022-04-01 → 2022-09-30¥42.7bn
—segment totalrevenue intersegment2022-04-01 → 2022-09-30¥860m
—segment totalsegment profit2022-04-01 → 2022-09-30¥4.4bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 522
ItemContextValueUnit
Profit lossPrior1YTDDuration3023000000JPY
Profit lossCurrentYTDDuration-1796000000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration151000000JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration236000000JPY
Profit loss attributable to owners of parentPrior1YTDDuration2871000000JPY
Profit loss attributable to owners of parentCurrentYTDDuration-2033000000JPY
Profit lossPrior1YTDDuration3023000000JPY
Profit lossCurrentYTDDuration-1796000000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration-156000000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration747000000JPY
Deferred gains or losses on hedges net of tax ociPrior1YTDDuration25000000JPY
Deferred gains or losses on hedges net of tax ociCurrentYTDDuration6000000JPY
Foreign currency translation adjustment net of tax ociPrior1YTDDuration773000000JPY
Foreign currency translation adjustment net of tax ociCurrentYTDDuration508000000JPY
Remeasurements of defined benefit plans net of tax ociPrior1YTDDuration-0JPY
Remeasurements of defined benefit plans net of tax ociCurrentYTDDuration-8000000JPY
Other comprehensive incomePrior1YTDDuration643000000JPY
Other comprehensive incomeCurrentYTDDuration1254000000JPY
Comprehensive incomePrior1YTDDuration3666000000JPY
Comprehensive incomeCurrentYTDDuration-542000000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration3282000000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration-855000000JPY
Comprehensive income attributable to non controlling interestsPrior1YTDDuration384000000JPY
Comprehensive income attributable to non controlling interestsCurrentYTDDuration313000000JPY
Income before income taxesPrior1YTDDuration4218000000JPY
Income before income taxesCurrentYTDDuration773000000JPY
Depreciation and amortization ope cfPrior1YTDDuration2191000000JPY
Depreciation and amortization ope cfCurrentYTDDuration2255000000JPY
Increase decrease in allowance for doubtful accounts ope cfPrior1YTDDuration-6000000JPY
Increase decrease in allowance for doubtful accounts ope cfCurrentYTDDuration-8000000JPY
Increase decrease in provision for bonuses ope cfPrior1YTDDuration12000000JPY
Increase decrease in provision for bonuses ope cfCurrentYTDDuration8000000JPY
Increase decrease in net defined benefit liability ope cfPrior1YTDDuration-0JPY
Increase decrease in net defined benefit liability ope cfCurrentYTDDuration-110000000JPY
Interest and dividends income ope cfPrior1YTDDuration-92000000JPY
Interest and dividends income ope cfCurrentYTDDuration-82000000JPY
Interest expenses ope cfPrior1YTDDuration36000000JPY
Interest expenses ope cfCurrentYTDDuration53000000JPY
Tender offer related expenses ope cfPrior1YTDDuration－JPY
Tender offer related expenses ope cfCurrentYTDDuration342000000JPY
Decrease increase in notes and accounts receivable trade ope cfPrior1YTDDuration1064000000JPY
Decrease increase in notes and accounts receivable trade ope cfCurrentYTDDuration-918000000JPY
Decrease increase in inventories ope cfPrior1YTDDuration-4860000000JPY
Decrease increase in inventories ope cfCurrentYTDDuration60000000JPY
Increase decrease in notes and accounts payable trade ope cfPrior1YTDDuration533000000JPY
Increase decrease in notes and accounts payable trade ope cfCurrentYTDDuration1183000000JPY
Other net ope cfPrior1YTDDuration-1526000000JPY
Other net ope cfCurrentYTDDuration158000000JPY
Subtotal ope cfPrior1YTDDuration1570000000JPY
Subtotal ope cfCurrentYTDDuration3716000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-09-30pass